Erythropoietin accelerates the revascularization of transplanted pancreatic islets

BACKGROUND AND PURPOSE: Pancreatic islet transplantation is a promising therapeutic approach for Type 1 diabetes. A major prerequisite for the survival of grafted islets is a rapid revascularization after transplantation. Erythropoietin (EPO), the primary regulator of erythropoiesis, has been shown...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Br J Pharmacol
Asıl Yazarlar: Menger, Maximilian M., Nalbach, Lisa, Roma, Leticia P., Körbel, Christina, Wrublewsky, Selina, Glanemann, Matthias, Laschke, Matthias W., Menger, Michael D., Ampofo, Emmanuel
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2020
Konular:
Research Papers
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7060362/
https://ncbi.nlm.nih.gov/pubmed/31721150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14925
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller